期刊文献+

西多福韦治疗复发性呼吸道乳头状瘤 被引量:1

原文传递
导出
摘要 复发性呼吸道乳头状瘤是好发于呼吸道的良性肿瘤,手术为其主要治疗方式,但不能根治,常联合辅助药物治疗。目前认为西多福韦可以减少手术次数,延长手术间隔时间。本文从安全性、有效性等方面对西多福韦辅助治疗复发性呼吸道乳头状瘤的进展做一综述。
作者 曾牧 王军
出处 《国际耳鼻咽喉头颈外科杂志》 2012年第5期270-272,共3页 International Journal of Otolaryngology-Head and Neck Surgery
基金 国家自然科学基金资助项目(8170900/H1302)
  • 相关文献

参考文献21

  • 1Xiong X,Smith JL, Chen MS. Effect of incorporation of cidofovir into DNA by human cytomegalovirus DNA polymerase on DNA elongation. Antimicrob Agents Chemother, 1997,41(3): 594-599.
  • 2Johnson JA,Gangemi JD. Selective inhibition of human papillomavirus-induced cell proliferation by (S) -1-[3-hydroxy-2-(phosphonylmethoxy) propyljcytosine. Antimicrob Agents Chemother, 1999, 43 (5):1198-1205.
  • 3吴剑波,郑家润.西多福韦的药理、毒理及其在皮肤科的应用[J].国外医学(皮肤性病学分册),2005,31(1):3-5. 被引量:4
  • 4Donne AJ, Hampson L,He XT, et al. Cidofovir induces an increase in levels of low-risk and high-risk HPV E6. Head Neck, 2009, 31 (7):893-901.
  • 5Wemer RD, Lee JH, Hoffman HT, et al. Case of progressive dysplasia concomitant with intralesional cidofovir administration for recurrent respiratory papillomatosis. Ann Otol Rhinol:Laryngol, 2005,114 (11): 836-839.
  • 6Broekema FI, Dikkers FG. Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol, 2008,265 (8):871-879.
  • 7Izzedine H, Launay-Vacher V, Deray G. Antiviral drug-induced nephrotoxicity. Am J Kidney Dis, 2005 , 45 (5):804-817.
  • 8Cundy KC. Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir. Clin Pharmacokinet, 1999, 36(2): 127-143.
  • 9Snoeck R, Wellens W, Desloovere C, et al. Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovirf (S) -1- (3- hydroxy-2-phosphonylmethoxypropyl) cytosine] . J Med Virol, 1998,54 (3):219-225.
  • 10Wiatrak BJ. Overview of recurrent respiratory papillomatosis. Curr Opin Otolaryngol Head Neck Surg, 2003,11 (6):433-441.

二级参考文献47

  • 1Bienvenu B, Martinez F, Devergie A, et al. Topical use of cidofovir induced acute renal failure. Transplantation, 2002, 73:661 -662.?A?A?A
  • 2Calista D, Regression of a cutaneous melanoma metastasis after intralesional cidofovir. Melanoma Res, 2003, 13:205 -206.
  • 3Bienvenu B, Martinez F, Devergie A, et al. Topical use of cidofovir induced acute renal failure. Transplantation, 2002, 73:661 -662.
  • 4Toro JR, Sanchez S, Turiansky G, et al. Topical cidofovir for the treatment of dermatologic conditions: verruca, condyloma, intraepithelial neoplasia, herpes simplex and its potential use in smallpox.Dermatol Clin, 2003, 21:301 - 309.?A
  • 5Xiong X, Smith JL, Chen MS. Effect of incorporation of cidofovir into DNA by human cytomegalovirus DNA polymerase on DNA elongation.Antimicrob Agents Chemother, 1997, 41:594-599.?A
  • 6Mendel DB, Barkhimer DB, Chen MS. Biochemical basis for increased susceptibility to cidofovir of herpes simplex viruses with altered or deficient thymidine kinase activity. Antimicrob Agents Chemother, 1995,39:2120 - 2122.?A
  • 7Johnson JA, Gangemi JD. Selective inhibition of human papillomavirus-induced cell proliferation by (S) - 1 - [ 3 -hydroxy -2 - (phosphonylmethoxy) propyl ] cytosine. Antimicrob Agents Chemother,1999, 43:1198 - 1205.?A
  • 8Andrei G, Snoeck R, Schols D, et al. Induction of apoptosis by cidofovir in human papillomavirus ( HPV ) - positive cells. Oncol Res,2000, 12:397-408.?A
  • 9Liekens S, Neyts J, De Clercq E, et al. Inhibition of fibroblast growth factor - 2 - induced vascular tumor formation by the acyclic nucleoside phosphonate cidofovir. Cancer Res, 2001,61:5057 -5064.?A?A
  • 10Cundy KC, Petty BG, Flaherty J, et al. Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother, 1995,39:1247-1252.?A

共引文献3

同被引文献12

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部